Henrik Jungaberle
Dr. sc. hum., CEO and founder of the MIND Foundation; Head of Development at OVID Clinic Berlin
Data updated
Research Footprint
Henrik Jungaberle appears in 11 tracked papers (2018–2026), most studied alongside Psilocybin, Placebo and LSD, across Depressive Disorders, Treatment-Resistant Depression (TRD) and Anxiety Disorders.
Most-cited paper: Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance (184 citations).
Frequent co-authors: Gerhard Gründer, Lea Mertens and Max Wolff.
Background & Research
Henrik Jungaberle is a German researcher with a doctorate in human sciences from Heidelberg University. He has worked for years in medical psychology, public health, psychoactive-substance research, and psychedelic therapy, and is the founder and executive director of the MIND Foundation. His work focuses on evidence-based psychedelic science, clinical implementation, and harm reduction in European healthcare settings.
Key Impact
He is a prominent European psychedelic research and implementation figure contributing to psilocybin clinical trials, harm reduction, and healthcare integration work.
Collaboration Network
9 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Henrik Jungaberle is associated with.